Are Nufarm shares a buy, hold or sell after jumping 13% on half-year results?

This agriculture company is set to keep rising.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Nufarm Ltd (ASX: NUF) shares were making headlines yesterday after the ASX materials stock soared 13% in a single session. 

Investors were gobbling up Nufarm shares after releasing its FY 2026 half-year results.

Happy female farmer holding fresh produce.

Image source: Getty Images

What did Nufarm report?

For the half year ended 31 March 2026, it reported: 

  • Statutory Net Profit After Tax $38 million, up 28% on the prior corresponding period (pcp)
  • Underlying NPAT (uNPAT) $52 million, up 35% on pcp
  • Underlying EBITDA (uEBITDA) $243 million, up 18% on pcp
  • $193 million improvement on pcp in free cash flow
  • Net debt $1.23 billion, a reduction of $135 million on pcp
  • Net debt to uEBITDA for twelve months to 31 March 2026 of 3.6x, a 20% reduction on pcp
  • FY26 Outlook for uEBITDA and Leverage reaffirmed.

Commenting on the announcement, Nufarm CEO Rico Christensen said 

We are pleased with first half performance and are well placed to deliver strong growth in underlying earnings and a significant reduction in leverage for the full year, consistent with previous guidance. 

We have made clear progress on the priorities we set in November last year, delivering earnings growth, improved cash flow and a reduction in leverage. The benefit of our increased strategic focus is visible in the margin improvement in Crop Protection and significant uplift in earnings from our Seed Technologies business.

Bell Potter weighs in 

Following this result, the team at Bell Potter issued updated guidance on Nufarm shares. 

Nufarm is one of the world's leading developers and manufacturers of seeds and crop protection solutions.

The broker noted that the company's Seeds business was a standout performer during the half. 

EBITDA more than doubled to $58 million, helped by significantly smaller losses in the omega-3 platform business.

Cash flow also improved compared with the prior year, and net debt declined to around $1.09 billion excluding leases. Debt levels finished the period in line with management guidance.

Looking ahead, management remains confident about FY26. 

The company expects strong earnings growth, supported by continued improvement in crop protection and further growth in the Seeds business. 

Nufarm is also progressing with its cost-saving program, targeting $50 million in annual savings by the end of FY26, with an additional $50 million reduction plan for FY27–28.

Upside in tact 

Based on this guidance, the team at Bell Potter retained their buy recommendation and $3.60 price target on Nufarm shares. 

From yesterday's closing price of $2.91, this indicates an upside potential of almost 24%. 

NUF is executing on its cost out initiatives ($32m of the $50m FY26e target achieved and a $50m target in FY27-28e) with a more favourable backdrop in crop protection markets and omega-3 (a doubling in fishoil pricing). Despite this NUF trades at a ~25% discount to global crop protection and seed peers.

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »

A couple in a supermarket laugh as they discuss which fruits and vegetables to buy
Broker Notes

Buy, hold, sell: Ramsay Health Care, PLS Group, Woolworths shares

Morgans has updated its ratings and 12-month price targets on these 3 ASX 200 shares.

Read more »

Broker Notes

WiseTech shares are bouncing back. Is it time to buy?

Could there be more upside ahead?

Read more »

Miner looks excited as he holds a nugget of gold he has discovered.
Broker Notes

Up 53%: Why this surging ASX All Ords gold stock just earned a major broker upgrade

A top broker forecasts this fast-rising ASX gold stock could rocket another 199%.

Read more »